An in-depth look to Bluejay Diagnostics, Inc. operating, investing, and financing activities

BJDX free cash flow for Q3 24 is -1.93 M USD. For 2023, BJDX free cash flow was -9.02 M USD and operating cash flow was -8.31 M USD.